---
figid: PMC8706759__MCO2-2-654-g003
figtitle: 'Targeting DNA repair pathway in cancer: Mechanisms and clinical application'
organisms:
- Homo sapiens
- Mus musculus
- Saccharomyces cerevisiae
- Drosophila melanogaster
- Deltapapillomavirus 4
- NA
organisms_ner:
- Drosophila melanogaster
- Homo sapiens
- Mus musculus
- Danio rerio
- Arabidopsis thaliana
pmcid: PMC8706759
filename: MCO2-2-654-g003.jpg
figlink: /pmc/articles/PMC8706759/figure/mco2103-fig-0003/
number: F3
caption: The interaction between DNA damage with immune responses. The activated STING
  pathway leads to upregulation of type I IFNs, which enhances the cross‐presentation
  of dendritic cells (DCs) and T‐cell activation. Unrepaired DNA damage may generate
  tumor neoantigens and thereby improving tumor recognition by T cells. However, DNA
  damage or DDR deficiencies have also been shown to upregulate PD‐L1 expression.
  cGAS, cyclic GMP–AMP synthase; DDR, DNA damage response; DC, dendritic cell; DSB,
  double‐strand break; ER, endoplasmic reticulum; IRF3, interferon regulatory factor
  3, IFN, interferon; NF‐κB, nuclear factor kappa‐B; STING, stimulator of interferon
  genes; TBK1, TANK‐binding kinase 1. Figure was created with bioRender
papertitle: 'Targeting DNA repair pathway in cancer: Mechanisms and clinical application.'
reftext: Manni Wang, et al. MedComm (2020). 2021 Dec;2(4):654-691.
year: '2021'
doi: 10.1002/mco2.103
journal_title: MedComm
journal_nlm_ta: MedComm (2020)
publisher_name: John Wiley and Sons Inc.
keywords: cancer | combination therapy | DNA damage response | PARP
automl_pathway: 0.9293898
figid_alias: PMC8706759__F3
figtype: Figure
redirect_from: /figures/PMC8706759__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8706759__MCO2-2-654-g003.html
  '@type': Dataset
  description: The interaction between DNA damage with immune responses. The activated
    STING pathway leads to upregulation of type I IFNs, which enhances the cross‐presentation
    of dendritic cells (DCs) and T‐cell activation. Unrepaired DNA damage may generate
    tumor neoantigens and thereby improving tumor recognition by T cells. However,
    DNA damage or DDR deficiencies have also been shown to upregulate PD‐L1 expression.
    cGAS, cyclic GMP–AMP synthase; DDR, DNA damage response; DC, dendritic cell; DSB,
    double‐strand break; ER, endoplasmic reticulum; IRF3, interferon regulatory factor
    3, IFN, interferon; NF‐κB, nuclear factor kappa‐B; STING, stimulator of interferon
    genes; TBK1, TANK‐binding kinase 1. Figure was created with bioRender
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - neb
  - Mhc
  - zip
  - Tcr
  - Pos
  - Dif
  - dl
  - Rel
  - Sting
  - aub
  - tefu
  - mei-41
  - put
  - RYa-R
  - chk
  - lok
  - dc
  - HSPA9
  - HLA-C
  - TRBV20OR9-2
  - TRA
  - TRB
  - TRD
  - TRG
  - NFKB1
  - STING1
  - IRF3
  - ATM
  - ATR
  - ANTXR1
  - MMAB
  - SERPINA2
  - CHKA
  - MATK
  - CHKB
  - IFNA1
  - CGAS
  - CD274
  - PDCD1
  - RPL17
  - RPL17-C18orf32
  - Trav6-3
  - Nfkb1
  - Sting1
  - Irf3
  - Atm
  - Tpm1
  - Atr
  - Mmab
  - Chka
  - Matk
  - Cgas
  - Cd274
  - Pdcd1
  - irf3
  - atm
  - atr
  - ifnphi1
  - cgasa
  - si:ch211-241b2.5
  - PD1
---
